557 related articles for article (PubMed ID: 33322749)
1. Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts.
Shi X; Young CD; Zhou H; Wang X
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322749
[TBL] [Abstract][Full Text] [Related]
2. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
[TBL] [Abstract][Full Text] [Related]
3. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
4. TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer.
Caja L; Dituri F; Mancarella S; Caballero-Diaz D; Moustakas A; Giannelli G; Fabregat I
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29701666
[TBL] [Abstract][Full Text] [Related]
5. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
6. Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.
Bordignon P; Bottoni G; Xu X; Popescu AS; Truan Z; Guenova E; Kofler L; Jafari P; Ostano P; Röcken M; Neel V; Dotto GP
Cell Rep; 2019 Aug; 28(9):2358-2372.e6. PubMed ID: 31461652
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.
Song M; He J; Pan QZ; Yang J; Zhao J; Zhang YJ; Huang Y; Tang Y; Wang Q; He J; Gu J; Li Y; Chen S; Zeng J; Zhou ZQ; Yang C; Han Y; Chen H; Xiang T; Weng DS; Xia JC
Hepatology; 2021 May; 73(5):1717-1735. PubMed ID: 33682185
[TBL] [Abstract][Full Text] [Related]
10. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
11. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
[TBL] [Abstract][Full Text] [Related]
12. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
[TBL] [Abstract][Full Text] [Related]
13. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
14. TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis.
Dees C; Pötter S; Zhang Y; Bergmann C; Zhou X; Luber M; Wohlfahrt T; Karouzakis E; Ramming A; Gelse K; Yoshimura A; Jaenisch R; Distler O; Schett G; Distler JH
J Clin Invest; 2020 May; 130(5):2347-2363. PubMed ID: 31990678
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic therapy to normalize the tumor microenvironment.
Hauge A; Rofstad EK
J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
[TBL] [Abstract][Full Text] [Related]
16. Targeting TGF-β signal transduction for fibrosis and cancer therapy.
Peng D; Fu M; Wang M; Wei Y; Wei X
Mol Cancer; 2022 Apr; 21(1):104. PubMed ID: 35461253
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.
Mulsow JJ; Watson RW; Fitzpatrick JM; O'Connell PR
Ann Surg; 2005 Dec; 242(6):880-7, discussion 887-9. PubMed ID: 16327498
[TBL] [Abstract][Full Text] [Related]
18. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance.
Chandra Jena B; Sarkar S; Rout L; Mandal M
Cancer Lett; 2021 Nov; 520():222-232. PubMed ID: 34363903
[TBL] [Abstract][Full Text] [Related]
19. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Δ-12, 14-prostaglandin J2 acts cooperatively with prednisolone to reduce TGF-β-induced pro-fibrotic pathways in human osteoarthritis fibroblasts.
Vaamonde-Garcia C; Malaise O; Charlier E; Deroyer C; Neuville S; Gillet P; Kurth W; Meijide-Failde R; Malaise MG; de Seny D
Biochem Pharmacol; 2019 Jul; 165():66-78. PubMed ID: 30936016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]